· Periodic Report
Q3 revenue KRW 1.7 billion, operating loss KRW 0.8 billion
SLS Bio sold KRW 1.7 billion in Q3 and lost KRW 0.8 billion from its main business, with sales up 459.7% from a year earlier and 27.8% from the prior quarter.
246250 · KOSDAQ · Based on DART filings
1 total · 20 per page
· Periodic Report
SLS Bio sold KRW 1.7 billion in Q3 and lost KRW 0.8 billion from its main business, with sales up 459.7% from a year earlier and 27.8% from the prior quarter.
Get app alerts for new disclosures from SLSBio(Specialty Lab Solution Bio) Co., Ltd.